Glenmark Life Sciences Key Metrics

BSE: 543322 | NSE: GLS | ISIN: INE03Q201024 | Sector: Biotechnology & Drugs

1,097.55 +48.65 (4.64%)Updated : 25 Nov 2024

Ratios

Return on average equity - 5 year average	30.83
Net Income/employee - trailing 12 month	21,02,781.00
Revenue/employee - most recent fiscal year	1,18,97,940.00
Return on investment - most recent fiscal year	20.40
Return on average assets - most recent fiscal year	16.96
Receivables turnover - most recent fiscal year	2.90
Return on investment - trailing 12 month	16.69
Return on average assets - trailing 12 month	14.03
Inventory turnover - most recent fiscal year	1.54
Inventory turnover - trailing 12 month	1.46
Revenue/employee - trailing 12 month	1,09,47,850.00
Return on average assets - 5 year average	18.28
Net Income/employee - most recent fiscal year	24,53,820.00
Return on average equity - trailing 12 month	17.18
Receivables turnover - trailing 12 month	2.79
Asset turnover - most recent fiscal year	0.82
Asset turnover - trailing 12 month	0.73
Return on average equity - most recent fiscal year	21.07
Return on investment - 5 year average	29.99

Trending Stocks

3,753.25+148.70(4.13%)

844.75+28.70(3.52%)

1,784.60+38.65(2.21%)

1,733.95-13.75 (-0.79%)

2,460.60-18.40 (-0.74%)

Related News